Prime Medicine (PRME) Amortizatization of Intangibles (2021 - 2024)
Prime Medicine (PRME) posted Amortizatization of Intangibles of $675000.0 for Q1 2024, down 37.96% on a QoQ basis from $1.1 million in Q4 2023, and up 10.47% year-over-year from $611000.0 in Q2 2023.
Prime Medicine (PRME) Amortizatization of Intangibles (2021 - 2024) Analysis & Trends
Prime Medicine's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $675000.0 for Q1 2024.
- Quarterly Amortizatization of Intangibles rose 10.47% year-over-year to $675000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $3.5 million (up 229.41% YoY) and the FY2023 annual result came in at $3.4 million, up 1263.2% from the prior year.
- Amortizatization of Intangibles was $675000.0 for Q1 2024 at Prime Medicine, down from $1.1 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.1 million in Q4 2023 and bottomed at -$715000.0 in Q4 2021.
- A 4-year average of $361800.0 and a median of $480500.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles soared 1514.29% — and 2024, when it advanced 10.47%.
- Prime Medicine's Amortizatization of Intangibles stood at -$715000.0 in 2021, then jumped by 148.95% to $350000.0 in 2022, then surged by 210.86% to $1.1 million in 2023, then tumbled by 37.96% to $675000.0 in 2024.
- Business Quant data shows PRME's Amortizatization of Intangibles at $675000.0 in Q1 2024, $1.1 million in Q4 2023, and $917000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Prime Medicine | 524.20 Mn | 524.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 675,000.00 |
| Mar 31, 2024 | 675,000.00 |
| Dec 31, 2023 | 1.09 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 917,000.00 |
| Sep 30, 2023 | 917,000.00 |
| Jun 30, 2023 | 792,000.00 |
| Jun 30, 2023 | 792,000.00 |
| Mar 31, 2023 | 611,000.00 |
| Mar 31, 2023 | 611,000.00 |
| Dec 31, 2022 | 350,000.00 |
| Dec 31, 2022 | 350,000.00 |
| Sep 30, 2022 | 149,000.00 |
| Sep 30, 2022 | 149,000.00 |
| Jun 30, 2022 | -56,000.00 |
| Jun 30, 2022 | -56,000.00 |
| Mar 31, 2022 | -193,000.00 |
| Mar 31, 2022 | -193,000.00 |
| Dec 31, 2021 | -715,000.00 |
| Dec 31, 2021 | -715,000.00 |